Altre lingue Procaps Group S.A.

Azioni

PROC

LU2376511205

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
2,71 ^USD	+0,37%		+0,74%	-33,42%

04/03	Procaps Group S.A. annuncia la formazione di un Comitato strategico per esplorare le alternative di creazione di valore	CI
04/03	Procaps Group annuncia la formazione di un comitato strategico per esplorare alternative di creazione di valore	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives	04/03
Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives	04/03
Procaps Group Announces Formation of Strategic Committee to Explore Value Creation Alternatives	04/03
Hoche Partners Pharma Holding S A Issues a Letter to Procaps Group, S A	20/02
Procaps Issues Shareholder Letter from New CEO	05/02
Declaration of Voting Results by Procaps Group, S A	24/01
Procaps Group – Notice to Shareholders	16/01
Hoche Partners Sends a Letter to Procaps Group	12/01
Procaps Group Reports Third Quarter 2023 Results	26/12
Procaps Group S.A. Provides Earnings Guidance for the Full Year 2023	26/12
Procaps S A : and subsidiaries (The Group) - Form 6-K	26/12
Procaps S A : Group Reports Third Quarter 2023 Results - Form 6-K	26/12
Procaps Group S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/12
Tranche Update on Procaps Group S.A.'s Equity Buyback Plan announced on June 1, 2023.	26/12
Statement from the Board of Directors of Procaps Group	22/12
Procaps Group Teams Up With Genomma Lab to Manufacture, Market Softgel Products in Latin America	30/11
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America	30/11
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America	29/11
Procaps Group and Genomma Lab Announce Strategic Agreement to Manufacture and Market Softgel Products in Latin America	29/11
Procaps Group Names Jose Antonio Vieira as CEO	22/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Procaps Group S.A.

Azioni

PROC

LU2376511205

Altre lingue

Filtri